Baltimore, USA
June 16 - June 18, 2002
This structured course for physicians and allied health professionals examined the main aspects of MS detection and treatment. The course reviewed ‘the state of the art’ for MS therapy and clarified the role of clinical trials in testing potential therapies. It stressed the benefits of new diagnostic tools for defining the natural history of MS and disease activity monitoring. Current diagnostic criteria and treatment for MS was also reviewed in the light of new medical evidence.
OBJECTIVES
At the conclusion of this course the participant was able to:
- Review the ‘state of the art’ in the therapeutic field of MS, with particular reference to new neuroprotective, immuno-modulating and anti-inflammatory drugs.
- Specify the design and pitfalls of clinical studies in MS.
- Explain the current state of the definition of new treatment options for MS.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Serono Symposia International,Inc., and the Consortium of MS Centers. Serono Symposia International, Inc., is accredited by the ACCME to provide continuing medical education for physicians.
Serono Symposia International, Inc., designates this education activity for a maximum of 14 credit hours in category I credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
CME accreditation for this program has been applied for from The Royal College of Physicians London, UK.
